Abstract
Aim The aim of this study was to explore suicidal patients’ experiences of safe clinical practice during hospitalisation in mental healthcare. The study was guided by the following research question: How do suicidal patients experience safe clinical practice during hospitalisation in mental health wards?
Design, setting and participants A qualitative design with semi-structured individual interviews was applied. Eighteen patients hospitalised with suicidal behaviour in specialised mental healthcare for adults at a Norwegian hospital participated in the study. Data were analysed thematically and inductively using qualitative content analysis.
Results Patients in a suicidal crisis experienced safe clinical care in mental health wards characterised by the following three themes: (1) being detected by mindful healthcare professionals, (2) receiving tailor-made treatment and (3) being protected by adaptive practice.
Conclusion This study illuminates the experiences of safe clinical practice for patients in a suicidal crisis. The patient group was multifaceted with fluctuating suicidal behaviour, which highlights the importance of embracing personalised activities. Safe clinical practice needs to recognise rather than efface patients’ variability.
Strengths and limitations of this study
• This study used qualitative interviews to provide rich and variable in-depth data of inpatients with suicidal behaviour, which is an under-researched group.
• Patient experience consultants were involved in the design of the study.
• The study results are suitable for conceptual development of safe clinical practice for suicidal patients.
• The patient sample provided rich variability regarding diagnoses, symptom/function level, sex, number of previous hospital admissions and compulsory/voluntary admissions.
• The qualitative methodological approach is not suited for assessing the effects of interventions.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://bmjopen.bmj.com/content/7/1/e012874
Funding Statement
This study received financial support from the Western Norway Regional Health Authority, grant number 911846.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets generated and/or analysed during the present study are not publicly available due to restrictions regarding individual privacy, but anonymised data are available from the corresponding author upon reasonable request.
